Chemoinformaics analysis of 2-(7-HEPTADECYNYLOXY)TETRAHYDRO-2H-PYRAN
| Molecular Weight | 336.56 | nRot | 14 |
| Heavy Atom Molecular Weight | 296.24 | nRig | 7 |
| Exact Molecular Weight | 336.303 | nRing | 1 |
| Solubility: LogS | -6.579 | nHRing | 1 |
| Solubility: LogP | 7.298 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 65.0157 |
| nHD | 0 | BPOL | 43.6003 |
| QED | 0.262 |
| Synth | 2.924 |
| Natural Product Likeliness | 0.556 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.831 |
| MDCK | 0.0000118 |
| BBB | 0.094 |
| PPB | 0.975076 |
| VDSS | 1.315 |
| FU | 0.00668644 |
| CYP1A2-inh | 0.185 |
| CYP1A2-sub | 0.202 |
| CYP2c19-inh | 0.448 |
| CYP2c19-sub | 0.094 |
| CYP2c9-inh | 0.139 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.144 |
| CYP2d6-sub | 0.04 |
| CYP3a4-inh | 0.282 |
| CYP3a4-sub | 0.046 |
| CL | 9.699 |
| T12 | 0.054 |
| hERG | 0.598 |
| Ames | 0.005 |
| ROA | 0.018 |
| SkinSen | 0.973 |
| Carcinogencity | 0.072 |
| EI | 0.975 |
| Respiratory | 0.477 |
| NR-Aromatase | 0.386 |
| Antiviral | Yes |
| Prediction | 0.592909 |